 |
70 Diseases |  |
70 Trials |
|
70 Trials |  |
2588 News |  |
| «12...42434445464748495051525354 |
- | Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
New P2 trial: SAIL-ON: Safety of Intravenous Thrombolytics in Stroke on Awakening (clinicaltrials.gov) - Jul 16, 2012
P2, N=20, Recruiting, Sponsor: Johns Hopkins University
- || Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
New P3 trial: EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International) (clinicaltrials.gov) - Apr 17, 2012
P3, N=200, Recruiting, Sponsor: National Stroke Research Institute, Australia
- Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
New P3 trial: Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study (clinicaltrials.gov) - Apr 9, 2012
P3, N=50, Recruiting, Sponsor: The Hospital for Sick Children
- ||| Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
Trial completion: Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas (clinicaltrials.gov) - Apr 6, 2012
P=N/A, N=100, Completed, Sponsor: Midwest Pulmonary and Critical Care
Recruiting --> Completed
- Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
Enrollment open: WASSABI: Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention (clinicaltrials.gov) - Mar 28, 2012
P2, N=90, Recruiting, Sponsor: Jacobs Neurological Institute
Recruiting --> Completed Not yet recruiting --> Recruiting
- Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
Trial initiation date, HEOR, Cost effectiveness: THRACE: Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke (clinicaltrials.gov) - Mar 19, 2012
P=N/A, N=480, Recruiting, Sponsor: Central Hospital, Nancy, France
Not yet recruiting --> Recruiting Initiation date: Feb 2010 --> Jun 2010
- Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
Enrollment open, HEOR, Cost effectiveness: THRACE: Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke (clinicaltrials.gov) - Mar 19, 2012
P=N/A, N=480, Recruiting, Sponsor: Central Hospital, Nancy, France
Initiation date: Feb 2010 --> Jun 2010 Not yet recruiting --> Recruiting
- | Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
Enrollment open: Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) (clinicaltrials.gov) - Mar 19, 2012
P3, N=3300, Recruiting, Sponsor: The George Institute
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- || Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
New P3 trial: Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke (clinicaltrials.gov) - Jan 31, 2012
P3, N=800, Recruiting, Sponsor: Universitätsklinikum Hamburg-Eppendorf
- |||||||||| Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
New P3 trial: SEATTLE II: Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (clinicaltrials.gov) - Jan 18, 2012
P3, N=150, Completed, Sponsor: EKOS Corporation
- |||| Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
Enrollment open: Assess the Penumbra System in the Treatment of Acute Stroke (clinicaltrials.gov) - Jan 3, 2012
P4, N=692, Recruiting, Sponsor: Penumbra Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | TNKASE (tenecteplase) / Roche, Boehringer Ingelheim, Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
New P2 trial: Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST) (clinicaltrials.gov) - Nov 15, 2011
P2, N=104, Recruiting, Sponsor: NHS Greater Glasgow and Clyde
- Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
Trial completion: IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion (clinicaltrials.gov) - Nov 6, 2011
P=N/A, N=7, Completed, Sponsor: University of North Carolina, Chapel Hill
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
New P2 trial: WASSABI: Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention (clinicaltrials.gov) - Oct 6, 2011
P2, N=90, Recruiting, Sponsor: Jacobs Neurological Institute
- ||||| Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
New P4 trial: Assess the Penumbra System in the Treatment of Acute Stroke (clinicaltrials.gov) - Sep 5, 2011
P4, N=692, Recruiting, Sponsor: Penumbra Inc.
- || Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
New P3 trial: Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) (clinicaltrials.gov) - Aug 22, 2011
P3, N=3300, Recruiting, Sponsor: The George Institute